Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel and Gemcitabine in Platinum-Resistant Ovarian Cancer
NCT00003449Phase 2Completed
- Sponsor
- University of Southern California
- Start
- May 1998
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, gemcitabine in ovarian cancer, sponsored by University of Southern California. Started May 1998; status: completed.
02
Drugs
paclitaxelgemcitabine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00003449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003449.